Haemonetics (HAE) Equity Ratio (2010 - 2026)
Haemonetics' quarterly Equity Ratio came in at 0.33 in Q1 2026, down 0.76% year-on-year from 0.33 in Q1 2025, and down 9.17% quarter-over-quarter from 0.37 in Q4 2025.
Haemonetics has reported Equity Ratio for 17 years, with the latest figure at 0.33 in Q1 2026.
- For the quarter ending Q1 2026, Equity Ratio fell 0.76% year-over-year to 0.33; the trailing twelve-month figure through Mar 2026 stood at 0.33 (down 0.76% YoY), and the FY2026 full-year result was 0.33, down 0.76% from the prior year.
- Equity Ratio for Q1 2026 stood at 0.33, down from 0.37 in the prior quarter.
- The five-year high for Equity Ratio was 0.44 in Q3 2023, with the low at 0.33 in Q1 2026.
- Average Equity Ratio over 5 years is 0.39, with a median of 0.39 recorded in 2022.
- Year-over-year, Equity Ratio retreated 26.87% in 2022 and increased 13.68% in 2023.
- Tracing HAE's Equity Ratio over 5 years: stood at 0.41 in 2022, then climbed by 3.76% to 0.43 in 2023, then decreased by 16.43% to 0.36 in 2024, then rose by 2.14% to 0.37 in 2025, then slipped by 9.17% to 0.33 in 2026.
- The last three Equity Ratio figures came in at 0.33 (Q1 2026), 0.37 (Q4 2025), and 0.35 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.47 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.50 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.54 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.59 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.78 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.45 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.29 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.67 |
| 10 | Haemonetics | 3.18 Bn | 2.93 Bn | 198.21 Mn | 0.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 0.33 |
| Dec 27, 2025 | 0.37 |
| Sep 27, 2025 | 0.35 |
| Jun 28, 2025 | 0.36 |
| Mar 29, 2025 | 0.33 |
| Dec 28, 2024 | 0.36 |
| Sep 28, 2024 | 0.35 |
| Jun 29, 2024 | 0.36 |
| Mar 30, 2024 | 0.44 |
| Dec 30, 2023 | 0.43 |
| Sep 30, 2023 | 0.44 |
| Jul 1, 2023 | 0.44 |
| Apr 1, 2023 | 0.42 |
| Dec 31, 2022 | 0.41 |
| Oct 1, 2022 | 0.39 |
| Jul 2, 2022 | 0.42 |
| Apr 2, 2022 | 0.40 |
| Jan 1, 2022 | 0.40 |
| Oct 2, 2021 | 0.39 |
| Jul 3, 2021 | 0.38 |
| Apr 3, 2021 | 0.40 |
| Dec 26, 2020 | 0.55 |
| Sep 26, 2020 | 0.47 |
| Jun 27, 2020 | 0.42 |
| Mar 28, 2020 | 0.46 |
| Dec 28, 2019 | 0.46 |
| Sep 28, 2019 | 0.49 |
| Jun 29, 2019 | 0.47 |
| Mar 30, 2019 | 0.52 |
| Dec 29, 2018 | 0.48 |
| Sep 29, 2018 | 0.55 |
| Jun 30, 2018 | 0.54 |
| Mar 31, 2018 | 0.61 |
| Dec 30, 2017 | 0.63 |
| Sep 30, 2017 | 0.63 |
| Jul 1, 2017 | 0.62 |
| Apr 1, 2017 | 0.60 |
| Dec 31, 2016 | 0.59 |
| Oct 1, 2016 | 0.56 |
| Jul 2, 2016 | 0.54 |
| Apr 2, 2016 | 0.55 |
| Dec 26, 2015 | 0.54 |
| Sep 26, 2015 | 0.55 |
| Jun 27, 2015 | 0.55 |
| Mar 28, 2015 | 0.56 |
| Dec 27, 2014 | 0.57 |
| Sep 27, 2014 | 0.56 |
| Jun 28, 2014 | 0.55 |
| Mar 29, 2014 | 0.55 |
| Dec 28, 2013 | 0.55 |
| Sep 28, 2013 | 0.54 |
| Jun 29, 2013 | 0.52 |
| Mar 30, 2013 | 0.53 |
| Dec 29, 2012 | 0.53 |
| Sep 29, 2012 | 0.53 |
| Jun 30, 2012 | 0.82 |
| Mar 31, 2012 | 0.80 |
| Dec 31, 2011 | 0.83 |
| Oct 1, 2011 | 0.82 |
| Jul 2, 2011 | 0.83 |
| Apr 2, 2011 | 0.82 |
| Jan 1, 2011 | 0.83 |
| Oct 2, 2010 | 0.81 |
| Jul 3, 2010 | 0.81 |
| Apr 3, 2010 | 0.78 |